Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ornstein
Rigas

Showing results (51-60 of 1,848) with videos related to

Pageof 185
Sort By:
Biochemical Society Transactions|July 27, 2005
Molecular targets of nitric-oxide-donating aspirin in cancerK Kashfi, B Rigas
Biochemical Society Transactions|July 27, 2005
Is COX-2 a 'collateral' target in cancer prevention?K Kashfi, B Rigas
International Journal of Oncology|June 15, 2006
NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review)Zhiquan Zhang, Basil Rigas
Diabetes, Obesity & Metabolism|June 13, 2009
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockersRigas Kalaitzidis, George Bakris
International Journal of Oncology|December 22, 2007
The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin)Basil Rigas, Vasiliki Kozoni
Canadian Journal of Nursing Administration|November 1, 1990
Collaborative practice between Ontario nurses and physicians: is it possible?H J Ornstein
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2005
Cancer prevention: a new era beyond cyclooxygenase-2Basil Rigas, Khosrow Kashfi
Cancer Research|October 17, 2008
The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agentsYu Sun, Basil Rigas
World Journal of Radiology|July 10, 2024
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury preventionPanagiotis Theofilis, Rigas Kalaitzidis
Journal of Hazardous Materials|April 15, 2004
Validation of turbulence models in heavy gas dispersion over obstaclesSpyros Sklavounos, Fotis Rigas
Pageof 185

Showing results (51-60 of 1,848) with videos related to

Sort By:
Pageof 185
Biochemical Society Transactions|July 27, 2005
Molecular targets of nitric-oxide-donating aspirin in cancerK Kashfi, B Rigas
Biochemical Society Transactions|July 27, 2005
Is COX-2 a 'collateral' target in cancer prevention?K Kashfi, B Rigas
International Journal of Oncology|June 15, 2006
NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review)Zhiquan Zhang, Basil Rigas
Diabetes, Obesity & Metabolism|June 13, 2009
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockersRigas Kalaitzidis, George Bakris
International Journal of Oncology|December 22, 2007
The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin)Basil Rigas, Vasiliki Kozoni
Canadian Journal of Nursing Administration|November 1, 1990
Collaborative practice between Ontario nurses and physicians: is it possible?H J Ornstein
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2005
Cancer prevention: a new era beyond cyclooxygenase-2Basil Rigas, Khosrow Kashfi
Cancer Research|October 17, 2008
The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agentsYu Sun, Basil Rigas
World Journal of Radiology|July 10, 2024
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury preventionPanagiotis Theofilis, Rigas Kalaitzidis
Journal of Hazardous Materials|April 15, 2004
Validation of turbulence models in heavy gas dispersion over obstaclesSpyros Sklavounos, Fotis Rigas
Pageof 185